Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.

Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.

Item

http://www.wikidata.org/entity/Q36099935

Q36099935

about

MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes MicroRNAs as pharmacological targets in diabetes MicroRNAs in autoimmune diseases The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing Issues and prospects of microRNA-based biomarkers in blood and other body fluids The two faces of miR-29 The pathogenic role of persistent milk signaling in mTORC1- and milk-microRNA-driven type 2 diabetes mellitus Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium Arsenic responsive microRNAs in vivo and their potential involvement in arsenic-induced oxidative stress Regulation of cardiac expression of the diabetic marker microRNA miR-29 MicroRNA Expression Varies according to Glucose Tolerance, Measurement Platform, and Biological Source.miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.MicroRNA-29b modulates innate and antigen-specific immune responses in mouse models of autoimmunity Environmental exposures in utero and microRNA.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review.MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development Blood-based signatures in type 1 diabetes.The microRNA-148/152 family: multi-faceted players MicroRNA-27a Induces Mesangial Cell Injury by Targeting of PPARγ, and its In Vivo Knockdown Prevents Progression of Diabetic Nephropathy Post-transcriptional Regulation of BRCA2 through Interactions with miR-19a and miR-19b Regulation of human adipogenesis by miR125b-5p A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis.MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.Profiling of circulating microRNAs in children with recent onset of type 1 diabetes.Alpinia oxyphylla Miq. extract changes miRNA expression profiles in db-/db- mouse kidney Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.MicroRNAs: Biomarkers, Diagnostics, and Therapeutics.Nucleic acid biomarkers of β cell stress and death in type 1 diabetes.Biomarkers of β-Cell Stress and Death in Type 1 Diabetes.MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections.Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.Polymorphisms in genes encoding miR-155 and miR-146a are associated with protection to type 1 diabetes mellitus.

P2860

Q26784462-D551622F-E522-4F20-B7FF-1833E7FC59EF Q26824024-981316FF-51EF-4AE8-A9C6-A6E895E4033A Q26824814-A140E98F-F04F-4742-80A6-B8E7EA89402D Q26827627-32A01978-8DE5-4C47-9D47-4BDFA0A3532F Q26991755-55DB28D8-4170-40C9-A668-25382EEDB452 Q26996481-3096F405-86B0-4E07-8FAD-DA9CFE5F3D94 Q27027262-41C2DE90-617C-4CD3-B8E9-C7B6A3307D4B Q27334532-3114A840-E4FC-4509-A322-969E018197B3 Q28305306-74D01945-2771-4C19-AC9A-4761C18FC5C2 Q28389940-8C955EFE-24A2-40FF-AFEB-9A88A031CBE3 Q28541217-C6DF768F-E1DA-403F-AD78-0B86784A8861 Q33654397-6A26E9D2-0904-427F-9CF4-0F621D4E4F82 Q33920162-B1A5A58A-A912-49CD-A553-70BDD706FF80 Q34155591-E034C61A-34B4-46A0-A4A5-015F02E4584B Q34252480-A87B0304-BD0D-4DA5-8573-0BB7751196B4 Q34391443-12732CAB-813A-4FDF-B751-ED47592D4C97 Q34461828-B211D1EF-F412-4473-8728-1EEE4B2972AE Q35674747-8CB9CA03-16B4-4C43-8086-12BD98EFB692 Q36075377-7875D58B-3A9E-4A24-BE2A-4DB9FA520A30 Q36109279-76D3F3D4-DBD4-4A5E-AD39-13FF5DAD8088 Q36552481-71EDDCC1-84B9-409A-820D-EAF2CA019788 Q36898251-81EED5F6-E702-40A5-B0C0-46A4B2D19A8B Q36906818-38F88214-3122-4EA7-BF89-73A189A8B366 Q37218177-7C3C7BE6-1758-4845-8A2B-6C16BA165B1C Q37237968-4D835F40-1328-4560-955E-D0D140BB6025 Q37393515-A9EFC9CC-2B3D-486B-A8B6-756D26C08C4B Q37565264-13C13DD9-220D-49D1-A396-AFE9C2AA07EF Q37646903-B4A4621F-82E1-4CCF-AD21-C2F9B4821129 Q37673402-637529B4-577E-49EB-8052-6C96535B65B4 Q37685243-5EC61EB8-DD0D-40BA-95C8-F460706D1E89 Q38429701-B633FBA9-2AF3-4694-845C-115080840281 Q38684417-0CEAB9A8-F9A1-4E8E-9204-8040C10CB199 Q38765883-76CD679D-84DD-4A1D-A121-C55544CCFD44 Q38851586-75E55609-EFD9-4B1B-85EE-41F75B73763D Q38931848-D1445A95-6D7C-4E56-85EC-357F174E3987 Q39008865-78F891C3-6EEB-4CE6-9418-14B308013C8D Q39141563-451F9996-C118-436D-A60B-FC1745D636DD Q39190427-9577125F-DDAE-4B79-A6AF-8DC90E60B166 Q39403789-9FADA46B-976C-4DC1-B584-A50543DAA083 Q40374047-93161488-6B0D-44B3-82CD-BF1AD39B121E

P2860

Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.

Item

http://www.wikidata.org/entity/Q36099935

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Circulating levels of microRNA ...... ol during disease progression.

@ast

Circulating levels of microRNA ...... ol during disease progression.

@en

type

Item

label

Circulating levels of microRNA ...... ol during disease progression.

@ast

Circulating levels of microRNA ...... ol during disease progression.

@en

prefLabel

Circulating levels of microRNA ...... ol during disease progression.

@ast

Circulating levels of microRNA ...... ol during disease progression.

@en

P1476

Circulating levels of microRNA ...... rol during disease progression

@en

P2093

Chen-Yu Zhang

http://www.w3.org/2001/XMLSchema#string

Kaspar Sørensen

http://www.w3.org/2001/XMLSchema#string

Lars Hansen

http://www.w3.org/2001/XMLSchema#string

Lotte B Nielsen

http://www.w3.org/2001/XMLSchema#string

Marie-Louise M Andersen

http://www.w3.org/2001/XMLSchema#string

Philip Hougaard

http://www.w3.org/2001/XMLSchema#string

P2860

RNA-Seq: a revolutionary tool for transcriptomics

Circulating microRNAs as stable blood-based markers for cancer detection.

A microRNA signature of hypoxia

MicroRNAs: small RNAs with a big role in gene regulation

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

MicroRNAs 103 and 107 regulate insulin sensitivity

Recent decline in age at breast development: the Copenhagen Puberty Study

The honeymoon phase: intersection of metabolism and immunology

miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells

microRNA functions

P304

896362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/896362

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

Claus Heiner Bang-Berthelsen

P577

2012-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230566062

http://www.w3.org/2001/XMLSchema#string

P698

22829805

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

microRNA

P932

3398606

http://www.w3.org/2001/XMLSchema#string

Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.

about

P2860

P2860

Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932